Axonics Inc (NAS:AXNX)
$ 67.22 -0.11 (-0.16%) Market Cap: 3.43 Bil Enterprise Value: 3.13 Bil PE Ratio: 0 PB Ratio: 5.47 GF Score: 83/100

Axonics Modulation Technologies Inc at Barclays Global Healthcare Conference Transcript

Mar 10, 2020 / 07:50PM GMT
Release Date Price: $32.03 (-0.99%)
Kristen Marie Stewart
Barclays Bank PLC, Research Division - Research Analyst

All right. Well, welcome, everybody, to the Barclays Global Healthcare fireside, beachside, desk-side chat. I'm Kristen Stewart, the medical supplies and device analyst. And it is my pleasure to have Axonics Modulation Technologies here for this lovely session here this afternoon.

With us here today, we have Ray Cohen, company's CEO; as well as Dan Dearen, the CFO.

And we're going to keep this fairly casual. We're going to have a question-and-answer session. (Operator Instructions)

So with that, I'm going to just kind of kick it off to Ray.

Questions & Answers

Kristen Marie Stewart
Barclays Bank PLC, Research Division - Research Analyst

So Ray, you guys have launched your Axonics Sacral Neuromodulation product here in the United States. You had your commercial launch, I guess, it was the end of October. I was wondering if you could just kind of share with the audience the early perspective that you may have on the launch of the product?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot